Vectiopep
PrivateLast Round
Grant
Apr 28, 2026
Total Funding Raised
$490,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vectiopep operates in Healthcare & Life Sciences and is based in Tartu. Its latest recorded funding round was a Seed round in April 2024.
Vectiopep is a biotechnology company that develops peptide-based nucleic acid delivery technology for cancer immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vectiopep Comparables
Compare Vectiopep with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Divincell | 85% | |
| Aanastra Inc. | 79% | |
| Altamira Therapeutics Ltd. | 78% |
For institutional investors. Book with your work email.
Vectiopep Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 28, 2026 | ||||
| Seed | Apr 10, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vectiopep Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| Estonian Business Angels Network | Seed |
| UniTartu Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
$580K raised from European Innovation Council.
- Apr 10, 2024
$490K round led by Dag Nurm and Ivo Remmelg
For institutional investors. Book with your work email.
Vectiopep Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vectiopep's valuation, stock price, and market status.
Is Vectiopep a public or private company?
Vectiopep is a private company.
What is the current stock price of Vectiopep?
Vectiopep is a private company, so its shares have no public market price. Caplight tracks Vectiopep's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vectiopep worth (valuation)?
Valuation information for Vectiopep is not publicly available.
Can I buy Vectiopep stock?
Vectiopep shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vectiopep's last funding round?
Vectiopep's most recent funding round was Grant on April 28, 2026.
Who are the main investors in Vectiopep?
Key investors in Vectiopep include European Innovation Council, Estonian Business Angels Network, UniTartu Ventures.
Will Vectiopep IPO soon?
No public IPO plans have been announced for Vectiopep.
How can I track Vectiopep secondary market activity?
Caplight tracks bids, offers, and trades in Vectiopep's shares on secondary markets.